81P Efficacy of weekly paclitaxel-bevacizumab combination...

Annals of Oncology 2019 / 12 Vol. 30; Iss. Supplement

81P Efficacy of weekly paclitaxel-bevacizumab combination in advanced non squamous non-small cell lung cancer (NSCLC) progressing after immune checkpoint inhibitors - AVATAX , a retrospective multicentric study: Preliminary data

Valery, S C, Chouaid, C, Rousseau-Bussac, G, Monnet, I, Bilger, G, Boré, P, Pinsolle, J, Descourt, R, Geier, M, Toffart, A C, Cony-Makhoul, P, Robinet, G, Ennahdi, F, Zaccaria, I, Decroisette, C
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz449.035
Date:
December, 2019
File:
PDF, 75 KB
2019
Conversion to is in progress
Conversion to is failed